Barriga, Danver Kayle .
HRN: 23-82-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/01/2023
10/03/2023
PO
5ml
BID
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes